China Pharma Holdings Inc (CPHI) support and resistance · rev $4.5M
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
This page maps China Pharma Holdings Inc (CPHI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
CPHI currently screens at market cap $29.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CPHI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CPHI quote page for the session range and the stock page for the full model.
Not investment advice.